Latest Contracts News

OncoSil Medical Ltd has launched an $8 million equity raising to fund the commercial expansion and clinical development of its targeted radiotherapy device for pancreatic cancer, aiming to capitalise on growing European market adoption and upcoming trial catalysts.

Theta Gold Mines Limited has released a Revised Feasibility Study for its TGME Gold Mine Project in South Africa, projecting robust economics with a 13.1-year mine life and first gold production slated for early 2027.

NRW Holdings has landed three major contracts worth approximately $270 million, reinforcing its footprint in mining and infrastructure projects across Western Australia. These wins highlight NRW’s expanding role in critical regional developments set to unfold over the next two years.

Memphasys has lodged regulatory submissions for its Felix™ System in Australia and India, following CE Mark approval, while progressing UK market entry under the CE Mark transition framework.

Rhythm Biosciences has secured a multi-year commercial manufacturing agreement with US-based Quansys Biosciences to produce ColoSTAT® reagent kits, paving the way for broader market rollout of its colorectal cancer diagnostic test.

5E Advanced Materials is raising up to $36 million through a stock offering to fund the development of its Fort Cady boron and lithium project in California. The capital raise comes amid ongoing concerns about the company’s ability to continue as a going concern without further financing.

Vection Technologies has secured a $2.2 million defence contract for its new FEDRA edge data appliance, marking a significant step in its AI-powered military technology portfolio under a $22.3 million framework agreement.

F.F.I. Holdings anticipates a modest decline in half-year profit, citing one-off lease expenses despite steady food operations.

The Mozambique Government’s approval to restart the TotalEnergies-led LNG project has accelerated construction and workforce mobilisation, positioning RBR Group to capitalise on significant near-term opportunities.

Imagion Biosystems has submitted its Investigational New Drug application to the U.S. FDA for its MagSense® HER2 Imaging Agent, marking a pivotal step toward launching a Phase 2 clinical trial for breast cancer detection.

Peak Processing Limited has completed a strategic rebrand and organisational restructure, securing new long-term manufacturing agreements and expanding product listings to strengthen its foothold in North America's regulated cannabis beverage markets.

Memphasys Limited secures significant repeat orders from Hamad Medical Corporation, marking a pivotal expansion of its Felix™ system across the MENA region.